Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant.
Collier AY, Brown CM, McMahan KA, Yu J, Liu J, Jacob-Dolan C, Chandrashekar A, Tierney D, Ansel JL, Rowe M, Sellers D, Ahmad K, Aguayo R, Anioke T, Gardner S, Siamatu M, Bermudez-Rivera L, Hacker MR, Madoff LC, Barouch DH. Collier AY, et al. Among authors: siamatu m. Sci Transl Med. 2022 Apr 20;14(641):eabn6150. doi: 10.1126/scitranslmed.abn6150. Epub 2022 Apr 20. Sci Transl Med. 2022. PMID: 35258323 Free PMC article.
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Yu J, et al. Among authors: siamatu m. N Engl J Med. 2022 Apr 21;386(16):1579-1580. doi: 10.1056/NEJMc2201849. Epub 2022 Mar 16. N Engl J Med. 2022. PMID: 35294809 Free PMC article. No abstract available.
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
McMahan K, Giffin V, Tostanoski LH, Chung B, Siamatu M, Suthar MS, Halfmann P, Kawaoka Y, Piedra-Mora C, Jain N, Ducat S, Kar S, Andersen H, Lewis MG, Martinot AJ, Barouch DH. McMahan K, et al. Among authors: siamatu m. Med. 2022 Apr 8;3(4):262-268.e4. doi: 10.1016/j.medj.2022.03.004. Epub 2022 Mar 17. Med. 2022. PMID: 35313451 Free PMC article.
Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
Chandrashekar A, Yu J, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Anioke T, Barrett J, Chung B, Hachmann NP, Lifton M, Miller J, Powers O, Sciacca M, Sellers D, Siamatu M, Surve N, VanWyk H, Wan H, Wu C, Pessaint L, Valentin D, Van Ry A, Muench J, Boursiquot M, Cook A, Velasco J, Teow E, Boon ACM, Suthar MS, Jain N, Martinot AJ, Lewis MG, Andersen H, Barouch DH. Chandrashekar A, et al. Among authors: siamatu m. Cell. 2022 Apr 28;185(9):1549-1555.e11. doi: 10.1016/j.cell.2022.03.024. Epub 2022 Mar 17. Cell. 2022. PMID: 35427477 Free PMC article.
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.
Cadena AM, Ventura JD, Abbink P, Borducchi EN, Tuyishime H, Mercado NB, Walker-Sperling V, Siamatu M, Liu PT, Chandrashekar A, Nkolola JP, McMahan K, Kordana N, Hamza V, Bondzie EA, Fray E, Kumar M, Fischinger S, Shin SA, Lewis MG, Siliciano RF, Alter G, Barouch DH. Cadena AM, et al. Among authors: siamatu m. Nat Commun. 2021 Mar 5;12(1):1474. doi: 10.1038/s41467-021-21724-0. Nat Commun. 2021. PMID: 33674572 Free PMC article.
SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice.
Love J, Rodriguez-Aponte S, Tostanoski L, Dalvie N, Johnston R, Jacob-Dolan C, Powers O, Hachmann N, Miller J, Hall K, Siamatu M, Mazurek C, Surve N, Barouch D. Love J, et al. Among authors: siamatu m. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2692315. doi: 10.21203/rs.3.rs-2692315/v1. Res Sq. 2023. PMID: 37163131 Free PMC article. Preprint.
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex.
Dagotto G, Ventura JD, Martinez DR, Anioke T, Chung BS, Siamatu M, Barrett J, Miller J, Schäfer A, Yu J, Tostanoski LH, Wagh K, Baric RS, Korber B, Barouch DH. Dagotto G, et al. Among authors: siamatu m. NPJ Vaccines. 2022 Oct 27;7(1):125. doi: 10.1038/s41541-022-00553-2. NPJ Vaccines. 2022. PMID: 36302778 Free PMC article.
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Yu J, et al. Among authors: siamatu m. medRxiv [Preprint]. 2022 Feb 7:2022.02.06.22270533. doi: 10.1101/2022.02.06.22270533. medRxiv. 2022. PMID: 35169817 Free PMC article. Updated. Preprint.
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
Chandrashekar A, Yu J, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Anioke T, Barrett J, Chung B, Hachmann NP, Lifton M, Miller J, Powers O, Sciacca M, Sellers D, Siamatu M, Surve N, VanWyk H, Wan H, Wu C, Pessaint L, Valentin D, Van Ry A, Muench J, Boursiquot M, Cook A, Velasco J, Teow E, Boon ACM, Suthar MS, Jain N, Martinot AJ, Lewis MG, Andersen H, Barouch DH. Chandrashekar A, et al. Among authors: siamatu m. bioRxiv [Preprint]. 2022 Feb 7:2022.02.06.479285. doi: 10.1101/2022.02.06.479285. bioRxiv. 2022. PMID: 35169798 Free PMC article. Updated. Preprint.
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts.
Collier AY, Brown CM, Mcmahan K, Yu J, Liu J, Jacob-Dolan C, Chandrashekar A, Tierney D, Ansel JL, Rowe M, Sellers D, Ahmad K, Aguayo R, Anioke T, Gardner S, Siamatu M, Bermudez Rivera L, Hacker MR, Madoff LC, Barouch DH. Collier AY, et al. Among authors: siamatu m. medRxiv [Preprint]. 2021 Oct 20:2021.10.18.21265113. doi: 10.1101/2021.10.18.21265113. medRxiv. 2021. PMID: 34704104 Free PMC article. Updated. Preprint.